A1M Pharma to prioritize the indication acute kidney injuries in further development of ROSgardTM on the basis of positive preclinical data
(World News Science)

Read A1M Pharma is today announcing the company`s decision to prioritize the indication acute kidney injuries in conjunction with heart surgery in the long-term clinical development plan for the drug candidate ROSgardTM. This decision is based on the recently communicated positive results from preclinical studies in relevant research models. After completion of a Phase I trial in healthy subjects, the results of which are expected in the first half of...